The latest cancer drugs news
Browsing: Cancer Drug News
ASCO 2020: Researchers underscore efficacy of pembrolizumab plus axitinib in treating advanced renal cell carcinoma
Researchers at Fox Chase Cancer Center, USA, along with an international team of investigators, have…
ASCO 2020: Pembrolizumab doubles time to disease progression in patients with advanced colorectal cancer with specific DNA mutations
Front-line therapy with the immune checkpoint inhibitor pembrolizumab doubled progression-free survival vs chemotherapy in patients…
ASCO 2020: Post-surgery osimertinib delays disease recurrence in patients with localised non-small cell lung cancer
Treatment with targeted therapy osimertinib following surgery for localised non-small cell lung cancer (NSCLC) with…
New drug combinations help overcome resistance to immunotherapy
A study from researchers at the UCLA Jonsson Comprehensive Cancer Center, USA, helps explain how…
Protected: Novel triplet therapy for newly diagnosed multiple myeloma patients now PBS listed
This content is password protected. To view it please enter your password below: Password:
Anti-malarial drug shows promise for brain cancer treatment
Glioblastoma multiforme (GBM) is an aggressive form of cancer in the brain that is typically…
High cost of new cancer drugs in US not related to their effectiveness, study shows
The high costs of recently licensed cancer medicines in the United States—as compared with those…
ASCO 2020: Adoptive T-cell therapy ADP-A2M4 targeting MAGE-A4 shows early activity in patients with advanced solid tumours
The adoptive T-cell therapy ADP-A2M4, which is engineered to express a T-cell receptor (TCR) directed…
FDA grants accelerated approval to rucaparib for BRCA-mutated metastatic castration-resistant prostate cancer
The Food and Drug Administration (FDA) granted accelerated approval to rucaparib for patients with deleterious…
FDA approves ripretinib for advanced gastrointestinal stromal tumour
The Food and Drug Administration (FDA) approved ripretinib, for adult patients with advanced gastrointestinal stromal…